Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
Main Authors: | Petousi, N, Pavord, ID, Kent, BD |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2024
|
Similar Items
-
Toward a predict and prevent approach in obstructive airway diseases
by: Couillard, S, et al.
Published: (2023) -
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
by: Conti, DM, et al.
Published: (2024) -
Key transcriptional regulators of neutrophil function in inflammation
by: Ai, Z
Published: (2021) -
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma
by: Howell, I, et al.
Published: (2024) -
Well-being driven: The key entrepreneurial trait leads to the
entrepreneurial success
by: Hassan, Mohamad Ghozali, et al.
Published: (2021)